SignatureFD’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $84.6K | Buy |
288
+71
| +33% | +$20.1K | ﹤0.01% | 1549 |
|
|
2026
Q1 | $60.5K | Buy |
217
+66
| +44% | +$19K | ﹤0.01% | 1615 |
|
|
2025
Q4 | $45.8K | Buy |
151
+1
| +0.7% | +$312 | ﹤0.01% | 1705 |
|
|
2025
Q3 | $42.1K | Sell |
150
-17
| -10% | -$4.63K | ﹤0.01% | 1728 |
|
|
2025
Q2 | $40.3K | Sell |
167
-45
| -21% | -$10.6K | ﹤0.01% | 1704 |
|
|
2025
Q1 | $51.6K | Sell |
212
-53
| -20% | -$15.9K | ﹤0.01% | 1552 |
|
|
2024
Q4 | $87.1K | Buy |
265
+31
| +13% | +$10.5K | ﹤0.01% | 1304 |
|
|
2024
Q3 | $78.3K | Sell |
234
-56
| -19% | -$17.8K | ﹤0.01% | 1341 |
|
|
2024
Q2 | $79.2K | Sell |
290
-39
| -12% | -$11.3K | ﹤0.01% | 1285 |
|
|
2024
Q1 | $114K | Sell |
329
-23
| -7% | -$7.56K | ﹤0.01% | 1116 |
|
|
2023
Q4 | $114K | Buy |
352
+48
| +16% | +$15K | ﹤0.01% | 1040 |
|
|
2023
Q3 | $109K | Sell |
304
-23
| -7% | -$8.87K | ﹤0.01% | 1001 |
|
|
2023
Q2 | $124K | Sell |
327
-130
| -28% | -$52.9K | ﹤0.01% | 959 |
|
|
2023
Q1 | $219K | Buy |
457
+52
| +13% | +$24.3K | 0.01% | 697 |
|
|
2022
Q4 | $170K | Sell |
405
-44
| -10% | -$17.8K | 0.01% | 761 |
|
|
2022
Q3 | $187K | Sell |
449
-85
| -16% | -$42.4K | 0.01% | 698 |
|
|
2022
Q2 | $264K | Sell |
534
-168
| -24% | -$87.5K | 0.01% | 587 |
|
|
2022
Q1 | $395K | Buy |
702
+30
| +4% | +$18.1K | 0.01% | 484 |
|
|
2021
Q4 | $508K | Sell |
672
-38
| -5% | -$28.4K | 0.02% | 391 |
|
|
2021
Q3 | $530K | Buy |
710
+159
| +29% | +$119K | 0.02% | 345 |
|
|
2021
Q2 | $355K | Sell |
551
-11
| -2% | -$6.7K | 0.01% | 468 |
|
|
2021
Q1 | $321K | Buy |
562
+39
| +7% | +$23.1K | 0.01% | 432 |
|
|
2020
Q4 | $305K | Buy |
523
+34
| +7% | +$19.4K | 0.01% | 394 |
|
|
2020
Q3 | $252K | Buy |
489
+55
| +13% | +$27.9K | 0.01% | 397 |
|
|
2020
Q2 | $196K | Buy |
434
+108
| +33% | +$47.7K | 0.01% | 458 |
|
|
2020
Q1 | $114K | Buy |
326
+154
| +90% | +$56.6K | 0.01% | 585 |
|
|
2019
Q4 | $64K | Buy |
172
+7
| +4% | +$2.47K | ﹤0.01% | 879 |
|
|
2019
Q3 | $55K | Hold |
165
| – | – | ﹤0.01% | 876 |
|
|
2019
Q2 | $52K | Sell |
165
-26
| -14% | -$7.79K | ﹤0.01% | 876 |
|
|
2019
Q1 | $58K | Sell |
191
-2
| -1% | -$540 | ﹤0.01% | 821 |
|
|
2018
Q4 | $45K | Buy |
193
+53
| +38% | +$14.2K | ﹤0.01% | 881 |
|
|
2018
Q3 | $44K | Hold |
140
| – | – | ﹤0.01% | 923 |
|
|
2018
Q2 | $40K | Sell |
140
-19
| -12% | -$5.25K | ﹤0.01% | 928 |
|
|
2018
Q1 | $40K | Buy |
+159
| New | +$40.5K | ﹤0.01% | 809 |
|
|
2016
Q4 | – | Sell |
-70
| Closed | -$11K | – | 349 |
|
|
2016
Q3 | $11K | Buy |
70
+50
| +250% | +$7.59K | ﹤0.01% | 983 |
|
|
2016
Q2 | $3K | Sell |
20
-22
| -52% | -$3.14K | ﹤0.01% | 1157 |
|
|
2016
Q1 | $6K | Buy |
42
+14
| +50% | +$1.84K | ﹤0.01% | 945 |
|
|
2015
Q4 | $4K | Buy |
+28
| New | +$3.88K | ﹤0.01% | 937 |
|
Other funds holding BIO
AI
SignatureFD's BIO Position: Q2 2026 in Review
SignatureFD increased its Bio-Rad Laboratories Class A (BIO) stake by 33% in Q2 2026, buying an estimated $20.1K and bringing the position to 288 shares worth $84.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1549.
SignatureFD first reported a position in BIO in Q4 2015 and has held it in 38 quarters since. The position peaked at $530K in Q3 2021. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.
- SignatureFD held 288 shares of Bio-Rad Laboratories Class A worth $84.6K as of Q2 2026.
- SignatureFD bought 71 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $20.1K.
- Bio-Rad Laboratories Class A made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1549 holding.
- SignatureFD first reported a position in Bio-Rad Laboratories Class A in Q4 2015 and has held it in 38 quarters since.
- SignatureFD's Bio-Rad Laboratories Class A position peaked at $530K in Q3 2021.
- 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.
Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.